Endo Health to buy Canadian peer Paladin Labs for $1.6 billion

(Reuters) - Specialty pharmaceutical company Endo Health Solutions Inc said it would acquire Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets. Endo will pay C$77 ($73.98) per Paladin share, representing a premium of more than 20 percent to Paladin's Monday close. (Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)



via Health News Headlines - Yahoo! News http://news.yahoo.com/endo-health-buy-canadian-peer-paladin-labs-1-120011986--finance.html